Ceprotin Treatment Registry

The overall objective is to collect and assess data on the treatment, safety, and treatment outcomes of subjects prescribed, receiving and participating in the Ceprotin treatment registry.

Lead sponsor: Baxalta now part of Shire•12 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

A Study of Freeze-dried Human Protein C Concentrate (TAK-662) in Participants With Congenital Protein C Deficiency

NCT06590974 · Protein C Deficiency

COMPLETEDPhase 1/2

A Study of TAK-662 for Japanese Patients With Congenital Protein C Deficiency

NCT04984889 · Congenital Protein C Deficiency

UNKNOWN

Ghrelin Levels in Patients With Protein C Deficiency

NCT04180657 · Protein C Deficiency

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 17, 2021Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment43

Start dateJun 2010

Last updatedMar 17, 2021

Condition

Protein C Deficiency

Locations shown

Phoenix, Arizona

Orange, California

Aurora, Colorado

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 17, 2021Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions